META-ANALYSIS OF DRUG ABUSE TREATMENT OUTCOME STUDIES

药物滥用治疗结果研究的荟萃分析

• 批准号: 3635541
• 负责人: DAVID M FRAM
• 金额: $ 9.63万
• 依托单位: BELMONT RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 1995
• 资助国家: 美国
• 起止时间: 1995-04-01 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3635541
• 关键词: computer data analysis; computer program /software; drug abuse information system; drug abuse therapy; human therapy evaluation; prognosis; statistics /biometry

The goal of this project is to provide the database infrastructure and software tools necessary to enable quantitative integration of published drug abuse treatment outcome studies. These facilities will allow health services researchers to take advantage of meta-analytic techniques to gain clearer insight into drug abuse treatment effectiveness than what can be achieved through the traditional narrative research overview. The Phase I project will consist of several activities designed to establish a baseline meta-analysis framework, including: (1) collection and abstraction of the relevant literature; (2) design and construction of a database to store the abstracted study parameters; (3) selection and integration of appropriate statistical software; and (4) development of mechanisms for regular updating and dissemination of the database and associated software. Building on this framework, Phase II of the project will focus on carrying out a variety of meta-analyses in order to generate estimates of treatment effectiveness that take into account such covariates as drug type, treatment modality, and client demographics. The Phase III commercialization activities might include on-going maintenance and enhancement of the drug abuse treatment outcome research database as well as adaptation of the approach to other important public health domains.

该项目的目标是提供数据库基础设施， 软件工具，使出版物的定量整合 药物滥用治疗结果研究。这些设施将使健康 服务研究人员利用元分析技术， 更清楚地了解药物滥用治疗的有效性， 通过传统的叙事研究实现概述。 第一阶段项目将包括若干活动， 建立一个基线荟萃分析框架，包括：（1）收集和 相关文献的摘要;（2）设计和建造 数据库，用于存储提取的研究参数;（3）选择和 整合适当的统计软件;以及（4）开发 定期更新和传播数据库的机制， 相关软件。 在这一框架的基础上，该项目的第二阶段将侧重于开展 进行各种荟萃分析，以产生治疗估计值， 考虑到诸如药物类型， 治疗方式和客户人口统计数据。III期 商业化活动可能包括持续的维护和 加强药物滥用治疗结果研究数据库，以及 作为对其他重要公共卫生领域方法的调整。